Global Daratumumab Market Growth 2025-2031

December 2025 | 81 pages | ID: G0C95D081FFEN
LP Information

Abstracts

The global Daratumumab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Daratumumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Daratumumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Daratumumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Daratumumab players cover Johnson?Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Daratumumab Industry Forecast” looks at past sales and reviews total world Daratumumab sales in 2024, providing a comprehensive analysis by region and market sector of projected Daratumumab sales for 2025 through 2031. With Daratumumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Daratumumab industry.

This Insight Report provides a comprehensive analysis of the global Daratumumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Daratumumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Daratumumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Daratumumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Daratumumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Daratumumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100mg Injection
• 400mg Injection

Segmentation by Application:

• Multiple Myeloma
• Diffuse Large B Cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Johnson?Johnson

Key Questions Addressed in this Report

What is the 10-year outlook for the global Daratumumab market?

What factors are driving Daratumumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Daratumumab market opportunities vary by end market size?

How does Daratumumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Daratumumab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Daratumumab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Daratumumab by Country/Region, 2020, 2024 & 2031
2.2 Daratumumab Segment by Type
  2.2.1 100mg Injection
  2.2.2 400mg Injection
2.3 Daratumumab Sales by Type
  2.3.1 Global Daratumumab Sales Market Share by Type (2020-2025)
  2.3.2 Global Daratumumab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Daratumumab Sale Price by Type (2020-2025)
2.4 Daratumumab Segment by Application
  2.4.1 Multiple Myeloma
  2.4.2 Diffuse Large B Cell Lymphoma
  2.4.3 Follicular Lymphoma
  2.4.4 Mantle Cell Lymphoma
  2.4.5 Others
2.5 Daratumumab Sales by Application
  2.5.1 Global Daratumumab Sale Market Share by Application (2020-2025)
  2.5.2 Global Daratumumab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Daratumumab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Daratumumab Breakdown Data by Company
  3.1.1 Global Daratumumab Annual Sales by Company (2020-2025)
  3.1.2 Global Daratumumab Sales Market Share by Company (2020-2025)
3.2 Global Daratumumab Annual Revenue by Company (2020-2025)
  3.2.1 Global Daratumumab Revenue by Company (2020-2025)
  3.2.2 Global Daratumumab Revenue Market Share by Company (2020-2025)
3.3 Global Daratumumab Sale Price by Company
3.4 Key Manufacturers Daratumumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Daratumumab Product Location Distribution
  3.4.2 Players Daratumumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DARATUMUMAB BY GEOGRAPHIC REGION

4.1 World Historic Daratumumab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Daratumumab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Daratumumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Daratumumab Market Size by Country/Region (2020-2025)
  4.2.1 Global Daratumumab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Daratumumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Daratumumab Sales Growth
4.4 APAC Daratumumab Sales Growth
4.5 Europe Daratumumab Sales Growth
4.6 Middle East & Africa Daratumumab Sales Growth

5 AMERICAS

5.1 Americas Daratumumab Sales by Country
  5.1.1 Americas Daratumumab Sales by Country (2020-2025)
  5.1.2 Americas Daratumumab Revenue by Country (2020-2025)
5.2 Americas Daratumumab Sales by Type (2020-2025)
5.3 Americas Daratumumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Daratumumab Sales by Region
  6.1.1 APAC Daratumumab Sales by Region (2020-2025)
  6.1.2 APAC Daratumumab Revenue by Region (2020-2025)
6.2 APAC Daratumumab Sales by Type (2020-2025)
6.3 APAC Daratumumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Daratumumab by Country
  7.1.1 Europe Daratumumab Sales by Country (2020-2025)
  7.1.2 Europe Daratumumab Revenue by Country (2020-2025)
7.2 Europe Daratumumab Sales by Type (2020-2025)
7.3 Europe Daratumumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Daratumumab by Country
  8.1.1 Middle East & Africa Daratumumab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Daratumumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Daratumumab Sales by Type (2020-2025)
8.3 Middle East & Africa Daratumumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Daratumumab
10.3 Manufacturing Process Analysis of Daratumumab
10.4 Industry Chain Structure of Daratumumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Daratumumab Distributors
11.3 Daratumumab Customer

12 WORLD FORECAST REVIEW FOR DARATUMUMAB BY GEOGRAPHIC REGION

12.1 Global Daratumumab Market Size Forecast by Region
  12.1.1 Global Daratumumab Forecast by Region (2026-2031)
  12.1.2 Global Daratumumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Daratumumab Forecast by Type (2026-2031)
12.7 Global Daratumumab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Johnson?Johnson
  13.1.1 Johnson?Johnson Company Information
  13.1.2 Johnson?Johnson Daratumumab Product Portfolios and Specifications
  13.1.3 Johnson?Johnson Daratumumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Johnson?Johnson Main Business Overview
  13.1.5 Johnson?Johnson Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Daratumumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Daratumumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg Injection
Table 4. Major Players of 400mg Injection
Table 5. Global Daratumumab Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Daratumumab Sales Market Share by Type (2020-2025)
Table 7. Global Daratumumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Daratumumab Revenue Market Share by Type (2020-2025)
Table 9. Global Daratumumab Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Daratumumab Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Daratumumab Sale Market Share by Application (2020-2025)
Table 12. Global Daratumumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Daratumumab Revenue Market Share by Application (2020-2025)
Table 14. Global Daratumumab Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Daratumumab Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Daratumumab Sales Market Share by Company (2020-2025)
Table 17. Global Daratumumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Daratumumab Revenue Market Share by Company (2020-2025)
Table 19. Global Daratumumab Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Daratumumab Producing Area Distribution and Sales Area
Table 21. Players Daratumumab Products Offered
Table 22. Daratumumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Daratumumab Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Daratumumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Daratumumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Daratumumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Daratumumab Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Daratumumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Daratumumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Daratumumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Daratumumab Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Daratumumab Sales Market Share by Country (2020-2025)
Table 35. Americas Daratumumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Daratumumab Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Daratumumab Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Daratumumab Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Daratumumab Sales Market Share by Region (2020-2025)
Table 40. APAC Daratumumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Daratumumab Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Daratumumab Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Daratumumab Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Daratumumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Daratumumab Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Daratumumab Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Daratumumab Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Daratumumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Daratumumab Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Daratumumab Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Daratumumab
Table 52. Key Market Challenges & Risks of Daratumumab
Table 53. Key Industry Trends of Daratumumab
Table 54. Daratumumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Daratumumab Distributors List
Table 57. Daratumumab Customer List
Table 58. Global Daratumumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Daratumumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Daratumumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Daratumumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Daratumumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Daratumumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Daratumumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Daratumumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Daratumumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Daratumumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Daratumumab Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Daratumumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Daratumumab Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Daratumumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Johnson?Johnson Basic Information, Daratumumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson?Johnson Daratumumab Product Portfolios and Specifications
Table 74. Johnson?Johnson Daratumumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Johnson?Johnson Main Business
Table 76. Johnson?Johnson Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Daratumumab
Figure 2. Daratumumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Daratumumab Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Daratumumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Daratumumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Daratumumab Sales Market Share by Country/Region (2024)
Figure 10. Daratumumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg Injection
Figure 12. Product Picture of 400mg Injection
Figure 13. Global Daratumumab Sales Market Share by Type in 2025
Figure 14. Global Daratumumab Revenue Market Share by Type (2020-2025)
Figure 15. Daratumumab Consumed in Multiple Myeloma
Figure 16. Global Daratumumab Market: Multiple Myeloma (2020-2025) & (K Pcs)
Figure 17. Daratumumab Consumed in Diffuse Large B Cell Lymphoma
Figure 18. Global Daratumumab Market: Diffuse Large B Cell Lymphoma (2020-2025) & (K Pcs)
Figure 19. Daratumumab Consumed in Follicular Lymphoma
Figure 20. Global Daratumumab Market: Follicular Lymphoma (2020-2025) & (K Pcs)
Figure 21. Daratumumab Consumed in Mantle Cell Lymphoma
Figure 22. Global Daratumumab Market: Mantle Cell Lymphoma (2020-2025) & (K Pcs)
Figure 23. Daratumumab Consumed in Others
Figure 24. Global Daratumumab Market: Others (2020-2025) & (K Pcs)
Figure 25. Global Daratumumab Sale Market Share by Application (2024)
Figure 26. Global Daratumumab Revenue Market Share by Application in 2025
Figure 27. Daratumumab Sales by Company in 2025 (K Pcs)
Figure 28. Global Daratumumab Sales Market Share by Company in 2025
Figure 29. Daratumumab Revenue by Company in 2025 ($ millions)
Figure 30. Global Daratumumab Revenue Market Share by Company in 2025
Figure 31. Global Daratumumab Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Daratumumab Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Daratumumab Sales 2020-2025 (K Pcs)
Figure 34. Americas Daratumumab Revenue 2020-2025 ($ millions)
Figure 35. APAC Daratumumab Sales 2020-2025 (K Pcs)
Figure 36. APAC Daratumumab Revenue 2020-2025 ($ millions)
Figure 37. Europe Daratumumab Sales 2020-2025 (K Pcs)
Figure 38. Europe Daratumumab Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Daratumumab Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Daratumumab Revenue 2020-2025 ($ millions)
Figure 41. Americas Daratumumab Sales Market Share by Country in 2025
Figure 42. Americas Daratumumab Revenue Market Share by Country (2020-2025)
Figure 43. Americas Daratumumab Sales Market Share by Type (2020-2025)
Figure 44. Americas Daratumumab Sales Market Share by Application (2020-2025)
Figure 45. United States Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Daratumumab Sales Market Share by Region in 2025
Figure 50. APAC Daratumumab Revenue Market Share by Region (2020-2025)
Figure 51. APAC Daratumumab Sales Market Share by Type (2020-2025)
Figure 52. APAC Daratumumab Sales Market Share by Application (2020-2025)
Figure 53. China Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 57. India Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Daratumumab Sales Market Share by Country in 2025
Figure 61. Europe Daratumumab Revenue Market Share by Country (2020-2025)
Figure 62. Europe Daratumumab Sales Market Share by Type (2020-2025)
Figure 63. Europe Daratumumab Sales Market Share by Application (2020-2025)
Figure 64. Germany Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 65. France Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Daratumumab Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Daratumumab Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Daratumumab Sales Market Share by Application (2020-2025)
Figure 72. Egypt Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Daratumumab Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Daratumumab in 2025
Figure 78. Manufacturing Process Analysis of Daratumumab
Figure 79. Industry Chain Structure of Daratumumab
Figure 80. Channels of Distribution
Figure 81. Global Daratumumab Sales Market Forecast by Region (2026-2031)
Figure 82. Global Daratumumab Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Daratumumab Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Daratumumab Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Daratumumab Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Daratumumab Revenue Market Share Forecast by Application (2026-2031)